Fed. Circ. Backs Toss Of AbbVie's Humira License Suit
The Federal Circuit on Monday affirmed the dismissal of a declaratory judgment suit AbbVie filed seeking to invalidate a patent it licensed from MedImmune for use in the blockbuster drug Humira,...To view the full article, register now.
Already a subscriber? Click here to view full article